Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APX001 drug-drug interaction study with itraconazole or rifampin in healthy adults
NL-OMON47992Phase 1Active, not recruiting
- Sponsor
- Amplyx Pharmaceuticals
- Start
- Oct 2019
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of fosmanogepix in mycoses (2 cohorts), sponsored by Amplyx Pharmaceuticals. Started Oct 2019; status: active, not recruiting.
02
Drugs
fosmanogepix
03
Conditions
mycoses
Beyond the preview
Go deeper on NL-OMON47992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47992.